BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,545 | -13.4% | 93,926 | +4.5% | 0.01% | -7.1% |
| Q2 2023 | $4,094 | +31.9% | 89,866 | +47.6% | 0.01% | +16.7% |
| Q4 2022 | $3,103 | -99.9% | 60,876 | +16.0% | 0.01% | 0.0% |
| Q3 2022 | $2,827,000 | -38.4% | 52,485 | -8.2% | 0.01% | -45.5% |
| Q4 2020 | $4,588,000 | -7.3% | 57,181 | -7.1% | 0.02% | -21.4% |
| Q3 2020 | $4,950,000 | -4.4% | 61,548 | +2.4% | 0.03% | -15.2% |
| Q2 2020 | $5,177,000 | +2.1% | 60,133 | -3.8% | 0.03% | -17.5% |
| Q1 2020 | $5,073,000 | -16.9% | 62,481 | -14.4% | 0.04% | 0.0% |
| Q4 2019 | $6,104,000 | -18.2% | 72,995 | -14.5% | 0.04% | -25.9% |
| Q3 2019 | $7,466,000 | +15.2% | 85,352 | +7.8% | 0.05% | +8.0% |
| Q2 2019 | $6,483,000 | -16.1% | 79,154 | -16.7% | 0.05% | -21.9% |
| Q1 2019 | $7,730,000 | +6.4% | 95,063 | -13.9% | 0.06% | -8.6% |
| Q4 2018 | $7,265,000 | -16.6% | 110,372 | -2.3% | 0.07% | -6.7% |
| Q3 2018 | $8,710,000 | +2.0% | 112,982 | -2.3% | 0.08% | -8.5% |
| Q2 2018 | $8,541,000 | +26.8% | 115,662 | +11.7% | 0.08% | +20.6% |
| Q1 2018 | $6,736,000 | +2.7% | 103,569 | +2.1% | 0.07% | 0.0% |
| Q4 2017 | $6,560,000 | +2.7% | 101,488 | -0.3% | 0.07% | -6.8% |
| Q3 2017 | $6,386,000 | +6.9% | 101,768 | +3.1% | 0.07% | -2.7% |
| Q2 2017 | $5,974,000 | +31.2% | 98,682 | +12.4% | 0.08% | +23.0% |
| Q1 2017 | $4,554,000 | +25.7% | 87,820 | +7.5% | 0.06% | +10.9% |
| Q4 2016 | $3,622,000 | +243.6% | 81,697 | +268.8% | 0.06% | +189.5% |
| Q3 2016 | $1,054,000 | -11.3% | 22,151 | -23.4% | 0.02% | -38.7% |
| Q1 2016 | $1,188,000 | -4.4% | 28,920 | -11.2% | 0.03% | -3.1% |
| Q4 2015 | $1,243,000 | -100.0% | 32,577 | -71.3% | 0.03% | -80.8% |
| Q4 2014 | $8,324,790,000 | +8.6% | 113,587 | +6.3% | 0.17% | +4.4% |
| Q3 2014 | $7,667,036,000 | +32.4% | 106,828 | +33.4% | 0.16% | +27.0% |
| Q2 2014 | $5,790,240,000 | +27.8% | 80,086 | +30.0% | 0.13% | +14.5% |
| Q1 2014 | $4,532,321,000 | +50.6% | 61,597 | +34.5% | 0.11% | +22.2% |
| Q3 2013 | $3,009,187,000 | +242.3% | 45,809 | +261.0% | 0.09% | -2.2% |
| Q2 2013 | $879,004,000 | – | 12,690 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |